BCPC BALCHEM CORPcompanySEC Filings & Insider Trading Activity 2026
Latest BALCHEM CORP (BCPC) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 20, 2026, a 10-Q quarterly report filed on October 21, 2025, an 8-K current report filed on April 30, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for BALCHEM CORP (BCPC) (SEC CIK 9326), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business model: Specialty chemicals and ingredients for health, nutrition, and performance markets
- • 2026 emphasis on regulatory impact of EPA's EtO Interim Decision affecting sterilization products and applications
Risk Factors
- • Regulatory/legal risk: Tariff and trade changes under the USMCA impacting exports and requiring compliance with evolving export duties and quotas
- • Geopolitical/macro risk: Supply chain disruption risk from Russia-Ukraine war and Middle East conflict causing material raw material access issues in Europe
Management Discussion & Analysis
- • Revenue $1,037M, up 8.8% YoY; Human Nutrition & Health up $59.1M (9.9%), Animal Nutrition & Health up $16.1M (7.5%), Specialty Products up $8.2M (6.2%)
- • Operating margin 20.2% vs 19.2%, earnings from operations $209.3M, up 14.4%; net earnings $154.8M, up 20.5%
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Risk Factors
- • New anti-dumping risk: EU provisional duties 95.4%-120.8% on Chinese choline chloride imports, effective July 1, 2025, final duties proposed 90.0%-115.9%
- • Regulatory risk update: EU anti-dumping measures on choline chloride may restrict market access, investigation initiated October 2024 with final measures expected by end 2025
Annual Reports Archive10-K
AI-powered analysis of BALCHEM CORP (BCPC) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of BALCHEM CORP (BCPC) 10-Q quarterly reports filed with SEC EDGAR.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $942.4M | $922.4M | $953.7M | $1.0B |
| Gross Profit | $280.5M | $302.1M | $336.2M | $370.6M |
| Operating Income | — | $159.2M | $182.9M | $209.3M |
| Net Income | — | $108.5M | $128.5M | $154.8M |
| Gross Margin | 29.8% | 32.7% | 35.3% | 35.7% |
| Op. Margin | — | 17.3% | 19.2% | 20.2% |
| Net Margin | — | 11.8% | 13.5% | 14.9% |
| Balance Sheet | ||||
| Total Assets | — | $1.6B | $1.6B | $1.7B |
| Equity | — | $1.1B | $1.1B | $1.3B |
| ROE | — | 10.3% | 11.2% | 12.3% |
Source: XBRL financial data from BALCHEM CORP (BCPC) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 30, 2026 | — | — | — |
8-K | Feb 20, 2026 | — | — | |
10-K | Feb 20, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 19, 2026 | — | — | |
8-K | Dec 10, 2025 | — | — | |
10-Q | Oct 21, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Jul 31, 2025 | Jun 30, 2025 | — | |
10-Q | Apr 24, 2025 | Mar 31, 2025 | — | |
10-K | Feb 21, 2025 | Dec 31, 2024 | — | |
10-Q | Oct 25, 2024 | Sep 30, 2024 | — | |
10-Q | Jul 26, 2024 | Jun 30, 2024 | — | |
10-Q | May 3, 2024 | Mar 31, 2024 | — | |
10-K | Feb 16, 2024 | Dec 31, 2023 | — | |
10-Q | Oct 27, 2023 | Sep 30, 2023 | — | |
10-Q | Jul 28, 2023 | Jun 30, 2023 | — | |
10-Q | Apr 28, 2023 | Mar 31, 2023 | — | |
10-K | Feb 24, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 4, 2022 | Sep 30, 2022 | — | |
10-Q | Jul 29, 2022 | Jun 30, 2022 | — | |
10-Q | Apr 29, 2022 | Mar 31, 2022 | — | |
10-K | Feb 24, 2022 | Dec 31, 2021 | — | |
10-Q | Oct 29, 2021 | Sep 30, 2021 | — | |
10-Q | Jul 30, 2021 | Jun 30, 2021 | — | |
10-Q | Apr 30, 2021 | Mar 31, 2021 | — | |
10-K | Feb 19, 2021 | Dec 31, 2020 | — |
Frequently Asked Questions
What are the latest BCPC SEC filings in 2026?
BALCHEM CORP (BCPC) has filed a 10-K annual report on February 20, 2026, a 10-Q quarterly report on October 21, 2025, an 8-K current report on April 30, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did BCPC file its most recent 10-K annual report?
BALCHEM CORP (BCPC) filed its most recent 10-K annual report on February 20, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view BCPC 10-Q quarterly reports?
BALCHEM CORP (BCPC)'s most recent 10-Q quarterly report was filed on October 21, 2025. SignalX displays every BCPC 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has BCPC filed recently?
BALCHEM CORP (BCPC)'s most recent 8-K was filed on April 30, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find BCPC insider trading activity (Form 4)?
SignalX aggregates every BCPC Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does BCPC file with the SEC?
BALCHEM CORP (BCPC) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new BCPC filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for BALCHEM CORP (BCPC).
What is BCPC's SEC CIK number?
BALCHEM CORP (BCPC)'s SEC CIK (Central Index Key) number is 9326. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 9326 to look up all BCPC filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find BCPC return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from BALCHEM CORP (BCPC) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of BALCHEM CORP SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 77+ filings.